Clinical Scorecard: Transformation of Lower-Grade Gliomas to Malignancy: The Role of Contrast Enhancement, Surgical Resection Extent, and Interval-Censored Analysis of Natural History

At a Glance

Key Highlights

• Malignant transformation is a critical event influencing prognosis and treatment timing.

• Preoperative imaging serves as the only risk marker before tissue acquisition.

• Interval-censored analysis provides a more accurate model for studying transformation timing.

• Contrast enhancement is assessed visually on MRI to determine malignancy.

• Surgical resection extent may impact the likelihood of malignant transformation.

Guideline-Based Recommendations

Diagnosis

• Histological confirmation required for LGG diagnosis.

• MRI used for initial radiological diagnosis and monitoring.

Management

• Surgical resection is a key component of management for LGGs.

Monitoring & Follow-up

• Regular surveillance MRIs are essential for tracking transformation.

Risks

• Malignant transformation can occur without clear radiological indicators.

Patient & Prescribing Data

Patients with adult-type diffuse gliomas, WHO grade 2 or 3.

Timing of adjuvant therapy is influenced by the occurrence of malignant transformation.

Clinical Best Practices

• Utilize comprehensive imaging protocols for accurate assessment of LGGs.

• Incorporate interval-censored analysis in studies of malignant transformation.

• Ensure multidisciplinary review of imaging findings to confirm transformation.

Related Resources & Content

1. Journal of Neuro-Oncology, 2020 -- Geographical Patterns of Malignant Transformation in Low-Grade Glioma Patients

2. Journal of Neuro-Oncology, 2022 -- Contemporary Approaches to the Surgical Treatment of Incidental Gliomas

3. Journal of Neuro-Oncology, 2016 -- Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis

4. Journal of Clinical Oncology, 2025 -- Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update

5. Journal of Neuro-Oncology — Patterns of Spatial Invasion in Temporal Lobe Glioblastoma Following Complete Resection of Contrast-Enhancing Tumors

6. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update | Journal of Clinical Oncology

7. Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802 - PMC

8. Risk factors for postoperative malignant progression of lower-grade gliomas: a systematic review and meta-analysis - ScienceDirect